Arima Genomics Study Highlights Power of Whole-Genome Rearrangement Detection in Lymphoid Cancers Arima Genomics, Inc., a biotechnology company focused on leveraging whole-genome sequence and structural information to deliver comprehensive insights for cancer therapy selection, has announced the publication of a…
Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening Wisdom Bioscience, a biotechnology company revolutionizing oral cancer diagnostics, has announced the formation of its Scientific Advisory Board (SAB) following a successful initial funding round. The SAB…
New Combination Therapy Demonstrates 47% Reduction in Event-Free Survival Events Why is this a game-changer for bladder cancer treatment? Merck, a global leader in healthcare, has announced groundbreaking results from the Phase 3 KEYNOTE-B15 trial, which demonstrated that the combination of…
Sarepta Supports Educational Ambitions of Duchenne Community with $5,000 Scholarships Why is supporting the education of individuals with Duchenne muscular dystrophy crucial for the future of rare disease treatment? Sarepta Therapeutics, a leader in precision genetic medicine for rare diseases,…
pureLiFi Sets a New Benchmark for High-Speed Wireless Connectivity at MWC 2026 pureLiFi, the global leader in light-based communications, is poised to redefine the landscape of wireless connectivity at the upcoming Mobile World Congress (MWC) 2026. With its revolutionary LiFi…
Realbotix Provides Financial Reporting Update Realbotix Corp. a leader in AI-powered humanoid robotics, provides an update on the timing for reporting its financial filings. The Company will file its audited annual financial statements for the year ended September 30, 2025,…
Rallybio and Candid Therapeutics Announce Transformative Merger and Oversubscribed Financing to Advance TCE Therapeutics for Autoimmune Diseases Rallybio Corporatin, and Candid Therapeutics, Inc. (“Candid”), a globally recognized clinical-stage biotechnology company specializing in T-cell engager (TCE) therapeutics for autoimmune diseases, have…
Thermo Fisher Scientific Launches Advanced Chromogenic Culture Media for Rapid Candida Detection, Including Drug-Resistant Candida auris Thermo Fisher Scientific, a global leader in serving science, has announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar,…
SIMO Expands Carrier Enablement Strategy to Power Resilient, Multi-Network Enterprise Fixed Wireless Access Deployments SIMO, a leader in innovative mobile connectivity solutions, today announced the expansion of its carrier enablement strategy to power resilient, multi-network enterprise Fixed Wireless Access (FWA)…
Bunge Completes Acquisition of IFF’s Soy Protein Concentrate, Lecithin, and Crush Business Bunge today announced the closing of its acquisition of the soy protein concentrate, lecithin, and soy crush businesses from International Flavors & Fragrances, Inc. This transaction aligns with…